Search results
Results from the WOW.Com Content Network
PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, [3] as well as patients with melanoma who previously received isolated perfusion.
Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication used to treat a number of types of cancer. [2] This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal ...
IL-2 was the first new therapy approved (1990 EU, 1992 US) for the treatment of metastatic melanoma in 20 years. [139] IL-2 may offer the possibility of a complete and long-lasting remission in this disease in a small percentage of people with melanoma. [ 140 ]
A huge advancement in cancer treatment after the Food and Drug Administration just approved a type of cell therapy for patients with late-stage melanoma.
A new therapy for metastatic melanoma was shown to be more effective than a leading immunotherapy for the skin cancer. New cell-based therapy for melanoma more effective than existing treatment ...
The treatment was initially developed in the early 1970s. [1] The several types of hepatic artery treatments are based on the observation that tumor cells get nearly all their nutrients from the hepatic artery, while the normal cells of the liver get about 70-80 percent of their nutrients and 50% their oxygen supply from the portal vein, and ...
In the current study, looking at the mouse model of melanoma — an aggressive form of skin cancer — the researchers found that mice which received aspirin developed fewer metastases than ...
Micrograph showing a PD-L1 positive non-small cell lung carcinoma. PD-L1 immunostain. As of 2019, pembrolizumab is used via intravenous infusion to treat inoperable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC) in certain situations, as a first-line treatment for metastatic bladder cancer in patients who cannot receive cisplatin-based chemotherapy and have high levels ...